# Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

> **NCT02195089** · PHASE1,PHASE2 · COMPLETED · sponsor: **BioLeaders Corporation** · enrollment: 19 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** BLS_ILS_E710c 500mg
- **DRUG:** BLS_ILB_710c 1000mg
- **DRUG:** BLS_ILS_E710c 1500mg

## Key facts

- **NCT ID:** NCT02195089
- **Lead sponsor:** BioLeaders Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02195089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02195089, "Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02195089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*